-
FIPB clears six investment proposals in pharma sector Foreign Investment Promotion Board clears proposals worth Rs. 855 crore
Ministries, including health, finance and commerce are deciding on conditions…
Read more -
GSK and the case for Indian pharma in China
It may provide India a platform to push for increased…
Read more -
We will be launching Alzumab in August. Right now there are about 5 million psoriatic patients in India
BANGALORE: Announcing Biocon’s Q1 results, company chairperson and managing director…
Read more -
India All Set to Revolutionize Copy Cat Image of Pharmaceutical Industries
Bangalore: India, the South Asian country is one of the world’s…
Read more -
Indian pharma companies under global scrutiny, no witch-hunt, say experts
The USFDA’s warning to Wockhardt over deficiencies in its manufacturing…
Read more -
Indian pharma market needs strong regulatory set-up: Kiran Mazumdar-Shaw
Biocon, which posted a net profit of 19% on Friday,…
Read more -
Insurers edgy over auto, pharma liability covers
MUMBAI: A host of recalls by auto companies and legal…
Read more -
Indian Pharma Companies To Face Strict U.S. Drug Approval Norms
Bangalore: In a major crackdown on illegal sale of India-originating…
Read more -
Drugs pricing row: 7 pharmaceutical companies move HC against Centre’s order
Seven more pharmaceutical companies including Novartis India Limited today moved…
Read more -
Aug 06 2013
Pharma industry challenges new drug pricing policyMove expected to delay introduction of low priced medicines in the market
Taking cue from Cipla and Alembic, many in the pharmaceutical…
Read more